Company profile

Ticker
VXRT
Exchange
Website
CEO
Wouter W. Latour
Employees
Incorporated in
Location
Fiscal year end
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., Nabi Biopharmaceuticals, Nabi, Nabi Biopharmaceuticals, North American Biologicals Inc
SEC CIK
IRS number
591212264

VXRT stock data

(
)

Calendar

12 Nov 19
10 Dec 19
31 Dec 19

News

Company financial data Financial data

Quarter (USD) Sep 19 Jun 19 Mar 19 Dec 18
Revenue 454K 85K 5.41M 1.77M
Net income -5.26M -5.64M -1.34M -4.9M
Diluted EPS -0.32 -0.39 -0.18 -0.69
Net profit margin -1159% -6632% -24.76% -277%
Operating income -4.71M -5M -448K -4.19M
Net change in cash 3.3M 7.88M -3.08M -6.48M
Cash on hand 19.54M 16.24M 8.36M 11.44M
Cost of revenue
Annual (USD) Dec 18 Dec 17
Revenue 4.16M 5.84M
Net income -18.01M -9.58M
Diluted EPS -2.9 -91.65
Net profit margin -433% -164%
Operating income -21.76M -10.02M
Net change in cash 9.87M
Cash on hand 11.44M 1.57M
Cost of revenue

Financial data from Vaxart earnings reports

Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: addressing, ahead, arm, Armistice, ASC, charter, cohort, coincide, composed, confirmation, expiry, hedge, liter, Master, MSA, nominating, orange, peak, regularly, repaid, robust, RPO, shareholder, SOW, unbilled, unsolicited
Removed: affiliated, anti, August, bankruptcy, collateralized, disseminate, flexibility, IgG, kickback, maturity, nonroutine, optimization, possession, responded, serum, venture